Q2 2021 Aptose Biosciences Inc Earnings Call Transcript

Aug 03, 2021 / 09:00PM GMT
Operator

Good afternoon. My name is Mary and I will be your conference operator today. I would like to welcome everyone to Aptose Biosciences conference call for second quarter ended June 30, 2021. (Operator Instructions) Thank you. As a reminder, this conference call may be recorded.

I would like to introduce Ms. Susan Pietropaolo. Please go ahead.

Susan M. Pietropaolo - SMP Communications, Inc. - Principal

Thank you, Mary. Good afternoon and welcome to the Aptose Biosciences conference call to discuss financial and operational results for the first quarter ended June 30, 2021. Joining me on today's call are Dr. William G. Rice, Chairman, President and CEO; Dr. Jotin Marango, Senior Vice President, Chief Financial Officer and Chief Business Officer; and Dr. Rafael Bejar, Senior Vice President, Chief Medical Officer.

Before we proceed, I would like to remind everyone that certain statements made during this call will include forward-looking statements within the meaning of U.S. and Canadian securities laws. Forward-looking statements reflect Aptose's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot